Targeting autophagy in skin diseases

J Mol Med (Berl). 2015 Jan;93(1):31-8. doi: 10.1007/s00109-014-1225-3. Epub 2014 Nov 19.

Abstract

Autophagy is a major intracellular degradative process by which cytoplasmic materials are sequestered in double-membraned vesicles and degraded upon fusion with lysosomes. Under normal circumstances, basal autophagy is necessary to maintain cellular homeostasis by scavenging dysfunctional or damaged organelles or proteins. In addition to its vital homeostatic role, this degradation pathway has been implicated in many different cellular processes such as cell apoptosis, inflammation, pathogen clearance, and antigen presentation and thereby has been linked to a variety of human disorders, including metabolic conditions, neurodegenerative diseases, cancers, and infectious diseases. The skin, the largest organ of the body, serves as the first line of defense against many different environmental insults; however, only a few studies have examined the effect of autophagy on the pathogenesis of skin diseases. This review provides an overview of the mechanisms of autophagy and highlights recent findings relevant to the role of autophagy in skin diseases and strategies for therapeutic modulation.

Publication types

  • Review

MeSH terms

  • Animals
  • Autophagy / physiology*
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / metabolism
  • Skin Diseases* / drug therapy
  • Skin Diseases* / metabolism